MACROGENICS INC (MGNX) Form 10-K Annual Reports
MACROGENICS INC (MGNX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MGNX
CIK: 1125345
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerSaralyn Williams
Audit LocationTysons, Virginia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-07 | 2026-10-06 | FORM 4 | 0001125345-26-000063 | View SEC Doc Filr Page |
| 144 | 2026-09-21 | — | 144 Filing | 0001628280-26-062884 | View SEC Doc Filr Page |
| S-8 | 2026-09-03 | — | S-8 | 0001125345-26-000062 | View SEC Doc Filr Page |
| 8-K/A | 2026-09-03 | 2026-09-03 | 8-K/A | 0001125345-26-000059 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-19 | FORM 4 | 0001706903-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001628280-26-058022 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0001588365-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001628280-26-057456 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001125345-26-000056 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003604 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001125345-26-000054 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001628280-26-051901 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-03 | — | SCHEDULE 13G/A Filing | 0000070858-26-000403 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002901 | View SEC Doc Filr Page |
| 8-K | 2026-07-23 | 2026-07-23 | 8-K | 0001125345-26-000050 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-20 | — | SCHEDULE 13G/A Filing | 0001104659-26-085111 | View SEC Doc Filr Page |
| 144 | 2026-07-13 | — | 144 Filing | 0001628280-26-048068 | View SEC Doc Filr Page |
| 8-K | 2026-07-08 | 2026-07-01 | 8-K | 0001125345-26-000047 | View SEC Doc Filr Page |
| 8-K | 2026-07-07 | 2026-06-30 | 8-K | 0001125345-26-000045 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-05 | — | SCHEDULE 13G Filing | 0001104659-26-071033 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | FORM 4 | 0001140119-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | FORM 4 | 0001566617-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | FORM 4 | 0001214939-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | FORM 4 | 0001722857-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | FORM 4 | 0001324059-26-000002 | View SEC Doc Filr Page |